A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer

Status:Active, not recruiting
Conditions:Lung Cancer, Lung Cancer
Therapuetic Areas:Oncology
Age Range:18 - Any
Start Date:August 6, 2015
End Date:August 14, 2019

Use our guide to learn which trials are right for you!

A Randomized Phase 2 Study of Abemaciclib (LY2835219) Versus Docetaxel in Patients With Stage IV Squamous Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

The main purpose of this study is to evaluate the effectiveness of the study drug known as
abemaciclib versus docetaxel in participants with stage IV squamous non-small cell lung
cancer (NSCLC) previously treated with platinum-based chemotherapy.

Inclusion Criteria:

- Confirmed diagnosis of stage IV NSCLC.

- Have progressed during or after platinum-based chemotherapy for advanced disease.

- Have not received prior treatment with docetaxel.

- Have availability of adequate formalin-fixed paraffin-embedded (FFPE) tumor derived

- Have adequate organ function including hematology, renal, and liver.

- Have good performance score (0-1).

- Have measureable disease per RECIST 1.1.

- Agree to use a reliable medically approved method of birth control.

Exclusion Criteria:

- Have received prior treatment with any cyclin dependent kinase (CDK) 4 and 6 inhibitor
or participated in a clinical trial with a CDK 4 and 6 inhibitor and the treatment
administered is not known.

- Are currently receiving treatment in a clinical trial involving an investigational
product or non-approved use of a drug or device.

- Have the presence of unstable central nervous system (CNS) metastasis.

- Have had major surgery (excluding biopsy) < 28 days of the initial dose of study drug.
We found this trial at
3550 Jerome Avenue
Bronx, New York 10467
(718) 920-4321
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Bronx, NY
Click here to add this to my saved trials
Click here to add this to my saved trials
Fayetteville, Arkansas 72703
Principal Investigator: Eric Schaefer
Phone: 479-587-1700
Fayetteville, AR
Click here to add this to my saved trials
Olympia, Washington 98502
Principal Investigator: Joseph Ye
Phone: 360-352-2900
Olympia, WA
Click here to add this to my saved trials
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Principal Investigator: Ramaswamy Govindan
Phone: 314-362-5737
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
Saint Louis, MO
Click here to add this to my saved trials
818 N. Emporia, #403
Wichita, Kansas 67214
(316) 262-4467
Cancer Center of Kansas The physicians of Cancer Center are hematologists and oncologists. The staff...
Wichita, KS
Click here to add this to my saved trials